The AHA is hosting calls for all hospital and health system leaders to provide the latest information on and answer questions about the COVID-19 pandemic. The next call is July 9 from 2:30-3:45 p.m. ET. Food and Drug Administration Commissioner Stephen Hahn, M.D., will address FDA’s response to the COVID-19 epidemic, including emergency use authorizations, remdesivir distribution and vaccine clinical trials. 

In addition, AHA Board Chair Melinda Estes, M.D., AHA President and CEO Rick Pollack and AHA senior leaders will give updates on advocacy, regulatory and policy developments, as well as the association’s efforts to support members in their efforts to combat COVID-19. 

Callers are encouraged to dial in at least 10-15 minutes in advance. Please dial 800-469-8538 and enter the participant passcode 43576#.

Related News Articles

Headline
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…
Headline
The Centers for Disease Control and Prevention's COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been…
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…